JAMA
US$ 21.62
glp-1 parkinson's disease Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Diseases | CNS Drugs A New Treatment Strategy for
Description
Galli, E
2024 Jan 5
Improved Glycemic Control and Energy Patients using Retatrutide often experience improved glycemic control, meaning more stable blood sugar levels throughout the day
MQ: Writing review & editing, Writing original draft
Similarly, another study explored the impacts of using GLP-1 medications in the pre-op setting before coronary artery bypass grafting compared clinical outcomes for patients who received continuous infusion of GLP-1 12 h before coronary artery bypass grafting and continuing for 48 h after the surgical procedure
